Xenogen

Xenogen, Life Sciences – Pharmaceuticals/BiotechnologyXenogen had it’s IPO in 2004 and was acquired by Caliper Life Sciences (now Perkin Elmer) in 2009.

Pamela Contag, President
Springboard Alumna 2000